News 2012
World AIDS Day 2012: PEPFAR’s Blueprint for an AIDS-Free Generation
Success motivates action. All of us are much more willing to continue to invest in something that has produced results than in something that hasn’t.
Read more: World AIDS Day 2012: PEPFAR’s Blueprint for an AIDS-Free Generation
In This Issue
Earlier this year the FDA approved an in-home HIV test kit to encourage people to learn their status even if they didn't want to get tested in a medical setting. In this issue we explore what you need to know about Orasure's In-Home HIV Test.
The Home HIV Test Kit: What You Should Know
You may discover OraQuick's In-Home HIV Test on the shelves of the pharmacy section at your local drugstore or Wal-Mart. Approved by the Food and Drug Administration in July 2012, the home HIV test is intended to reduce the number of people who have HIV but don't know it.
Justice Department: Fighting Discrimination against People Living with HIV
The U.S. Department of Justice (DOJ) is responsible for enforcing Federal laws and ensuring fair and impartial administration of justice for all Americans. DOJ’s Civil Rights Division works to eradicate discrimination against people with disabilities, including those living with HIV or AIDS, by enforcing the Americans with Disabilities Act (ADA). The ADA prohibits discrimination by employers based on disability, and requires state and local governments and public accommodations, like doctors’ offices, medical clinics, hospitals, and other health care providers, to provide people with HIV equal access to goods, services, facilities, privileges, accommodations, and advantages.
Read more: Justice Department: Fighting Discrimination against People Living with HIV
Protease Inhibitors Linked to Higher Anal Cancer Rate in US Group
Longer treatment with protease inhibitors (PIs) independently raised the anal cancer rate in a study of men and women in California’s Kaiser Permanente healthcare system. Longer antiretroviral use lowered rates of AIDS-defining cancers.
Read more: Protease Inhibitors Linked to Higher Anal Cancer Rate in US Group